Metabolic Glycoengineering of Synthetic “Membrane Receptors” via Supramolecular Host–Guest Recognition
Bioconjugate Chemistry · 15.04.2026 · 37 (4) · 693-698
DOI: 10.1021/acs.bioconjchem.6c00076 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, online erschienen am 27.03.2026. Verfasst von Dongping Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Notre Dame, Department of Chemical & Biomolecular Engineering, Notre Dame, Indiana 46556, United States. Hauptthemen laut MEDLINE: Bridged-Ring Compounds, Adamantane, Imidazoles, Hexosamines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, U.S. Department of Health and Human Services, National Science Foundation.
Abstract (Originalsprache)
Metabolic glycoengineering enables the installation of unnatural chemical motifs on cell-surface glycoconjugates by leveraging endogenous biosynthetic pathways, yet prior efforts have primarily emphasized covalent chemistries. In this work, high-affinity supramolecular recognition motifs are introduced onto mammalian cell surfaces by using N-acyl-modified mannosamine precursors bearing adamantane guests for cucurbit[7]uril (CB[7]) complexation. A series of adamantane-mannosamine derivatives with varied linker lengths are synthesized and evaluated for metabolic incorporation in Jurkat and MCF-7 cells. Efficient conversion to adamantane-modified sialic acids and presentation at the cell membrane is achieved only for the shortest linker architecture, as confirmed by fluorescence labeling, flow cytometry, and direct mass spectrometric detection of modified sialic acids. Incorporation efficiency exhibited a strong dependence on both linker length and incubation time, revealing steric constraints imposed by the sialic acid biosynthetic machinery. Exploiting this supramolecular handle, a CB[7]-drug conjugate showed enhanced cytotoxicity in metabolically labeled cells. These results establish metabolic glycoengineering as a viable strategy for installing noncovalent, high-affinity supramolecular recognition motifs on cell surfaces, expanding the scope of orthogonal targeting approaches in biological environments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Notre Dame, Department of Chemical & Biomolecular Engineering, Notre Dame, Indiana 46556, United States.
ORCID-Profile: Matthew J Webber
Förderung
- NIGMS NIH HHS
- U.S. Department of Health and Human Services
- National Science Foundation
Zitieren
APA
Liu, D., Zou, L., Fan, B., Chi, T., Gates, B. D., Su, B., & Webber, M. J. (2026). Metabolic Glycoengineering of Synthetic “Membrane Receptors” via Supramolecular Host–Guest Recognition. Bioconjugate Chemistry, 37(4), 693-698. https://doi.org/10.1021/acs.bioconjchem.6c00076
Vancouver
Liu D, Zou L, Fan B, Chi T, Gates BD, Su B, et al. Metabolic Glycoengineering of Synthetic “Membrane Receptors” via Supramolecular Host–Guest Recognition. Bioconjugate Chemistry. 2026;37(4):693-698. doi:10.1021/acs.bioconjchem.6c00076
BibTeX
@article{Liu2026,
author = {Liu, Dongping and Zou, Lei and Fan, Bowen and Chi, Teng and Gates, Brant D and Su, Bo and Webber, Matthew J},
title = {Metabolic Glycoengineering of Synthetic “Membrane Receptors” via Supramolecular Host–Guest Recognition},
journal = {Bioconjugate Chemistry},
year = {2026},
volume = {37},
number = {4},
pages = {693--698},
doi = {10.1021/acs.bioconjchem.6c00076}
}
EUVIMED